Friess H - Search Results

1

Heparin-induced thrombocytopenia (HIT II) in liver transplant recipients: a retrospective multivariate analysis of prognostic factors.

Hüser N, Aßfalg V, Reim D, Novotny A, Thorban S, Cheng Z, Kornberg A, Friess H, Büchler P, Matevossian E. Hüser N, et al. Among authors: friess h. Transpl Int. 2012 Jul;25(7):739-47. doi: 10.1111/j.1432-2277.2012.01486.x. Epub 2012 Apr 30. Transpl Int. 2012. PMID: 22548256 Free article.

2

Connective tissue growth factor is involved in pancreatic repair and tissue remodeling in human and rat acute necrotizing pancreatitis.

di Mola FF, Friess H, Riesle E, Koliopanos A, Büchler P, Zhu Z, Brigstock DR, Korc M, Büchler MW. di Mola FF, et al. Among authors: friess h. Ann Surg. 2002 Jan;235(1):60-7. doi: 10.1097/00000658-200201000-00008. Ann Surg. 2002. PMID: 11753043 Free PMC article.

3

Adjuvant therapy in operable pancreatic cancer.

Wente MN, Büchler P, Friess H, Büchler MW. Wente MN, et al. Among authors: friess h. Swiss Surg. 2002;8(2):74-80. doi: 10.1024/1023-9332.8.2.74. Swiss Surg. 2002. PMID: 12013694

4

VEGF-RII influences the prognosis of pancreatic cancer.

Büchler P, Reber HA, Büchler MW, Friess H, Hines OJ. Büchler P, et al. Among authors: friess h. Ann Surg. 2002 Dec;236(6):738-49; discussion 749. doi: 10.1097/00000658-200212000-00006. Ann Surg. 2002. PMID: 12454512 Free PMC article.

5

Invasion and metastasis in pancreatic cancer.

Keleg S, Büchler P, Ludwig R, Büchler MW, Friess H. Keleg S, et al. Among authors: friess h. Mol Cancer. 2003 Jan 22;2:14. doi: 10.1186/1476-4598-2-14. Mol Cancer. 2003. PMID: 12605717 Free PMC article. Review.

6

Origin and development of the precursor lesions in experimental pancreatic cancer in rats.

Bockman DE, Guo J, Büchler P, Müller MW, Bergmann F, Friess H. Bockman DE, et al. Among authors: friess h. Lab Invest. 2003 Jun;83(6):853-9. doi: 10.1097/01.lab.0000074918.31303.5a. Lab Invest. 2003. PMID: 12808120 Free article.

7

Labor legislation in the European Union has impact on workforce management in surgical centers.

Büchler P, Kraus TW, Friess H, Büchler MW. Büchler P, et al. Among authors: friess h. Surgery. 2003 Jul;134(1):3-11. doi: 10.1067/msy.2003.161. Surgery. 2003. PMID: 12874572 No abstract available.

8

Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression.

Büchler P, Reber HA, Büchler MW, Friess H, Lavey RS, Hines OJ. Büchler P, et al. Among authors: friess h. Cancer. 2004 Jan 1;100(1):201-10. doi: 10.1002/cncr.11873. Cancer. 2004. PMID: 14692041 Free article.

9

Combination therapy for advanced pancreatic cancer using Herceptin plus chemotherapy.

Büchler P, Reber HA, Eibl G, Roth MA, Büchler MW, Friess H, Isacoff WH, Hines OJ. Büchler P, et al. Among authors: friess h. Int J Oncol. 2005 Oct;27(4):1125-30. Int J Oncol. 2005. PMID: 16142331

10

Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.

Schneider M, Büchler P, Giese N, Giese T, Wilting J, Büchler MW, Friess H. Schneider M, et al. Among authors: friess h. Int J Oncol. 2006 Apr;28(4):883-90. Int J Oncol. 2006. PMID: 16525637

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,238 results

Search Page

Filters